Back
Windtree Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
WINT
Windtree Therapeutics
Last Price:
$0.33
Seasonality Move:
-9.01%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Sell |
| 20-day SMA: | 0.43 | Sell |
| 50-day SMA: | 0.59 | Sell |
| 200-day SMA: | 4.12 | Sell |
| 8-day EMA: | 0.36 | Sell |
| 20-day EMA: | 0.43 | Sell |
| 50-day EMA: | 1.01 | Sell |
| 200-day EMA: | 8.89 | Sell |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 30.42 | Sell |
| Chaikin Money Flow: | 297647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.52) | Sell |
| Bollinger Bands (100): | (-0.61 - 7.41) | Sell |
Windtree Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.34 while WINT 8-day simple moving average is 0.36, which is a Sell signal.
-
The stock price of WINT is 0.34 while Windtree Therapeutics 20-day SMA is 0.43, which makes it a Sell.
-
Windtree Therapeutics 50-day simple moving average is 0.59 while WINT share price is 0.34, making it a Sell technically.
-
WINT stock price is 0.34 and Windtree Therapeutics 200-day simple moving average is 4.12, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
17
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a SellThe current Windtree Therapeutics [WINT] share price is $0.34. The Score for WINT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
3M
Price in USD:
0.34
Share Volume:
457.9K
Windtree Therapeutics 52-Week Range
52-Week High:
14.75
52-Week Low:
0.32
Sell
17
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 0.34 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.34 while WINT 8-day exponential moving average is 0.36, which is a Sell signal.
-
The stock price of WINT is 0.34 while Windtree Therapeutics 20-day EMA is 0.43, which makes it a Sell.
-
Windtree Therapeutics 50-day exponential moving average is 1.01 while WINT share price is 0.34, making it a Sell technically.
-
WINT stock price is 0.34 and Windtree Therapeutics 200-day simple moving average is 8.89, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Windtree Therapeutics is a Sell
-
Windtree Therapeutics Relative Strength Index (RSI) is 30.42, which suggest Windtree Therapeutics is oversold
-
The Bollinger Bands (25) for Windtree Therapeutics is (0.36 - 0.52), which suggest Windtree Therapeutics is a Sell
-
The Bollinger Bands (100) for Windtree Therapeutics is (-0.61 - 7.41), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.